Prof. Dror Harats, M.D. | Chief Executive Officer
Erez Feige, Ph.D. , M.B.A. | Vice President, Business Operations
Amos Ron | Chief Financial Officer
Eyal Breitbart, Ph.D. | Vice President, Research & Operations
Tami Rachmilewitz, M.D. | Vice President, Clinical Development
Yael Cohen, M.D. | Medical Director
Naamit Sher, Ph.D. | Vice President, Development and Regulatory
Dr. Sher Joined VBL in 2006. She was previously Head of QC Laboratories, Operations Division at Teva, and QC/QA Director at InterPharm, Subsidiary of Ares-Serono gaining 15 years of drug development and regulatory experience. Dr. Sher holds a Ph.D. from the Hebrew University, Israel and completed a post-doctoral fellowships at the Hebrew University, Jerusalem and at Rutgers University, New Jersey, U.S.